There is a worldwide problem of disease caused by Mycoplasma (M.) bovis in cattle; it has a significant detrimental economic and animal welfare impact on cattle rearing. Infection can manifest as a plethora of clinical signs including mastitis, pneumonia, arthritis, keratoconjunctivitis, otitis media and genital disorders that may result in infertility and abortion. Current diagnosis and control information are reviewed and analysed to identify gaps in knowledge of the causative organism in respect of the disease pathology, diagnosis and control methods. The main considerations are as follows: no vaccines are commercially available; antimicrobial resistance is increasing; diagnostic and antimicrobial sensitivity testing needs to be improved; and a pen-side test would facilitate more rapid diagnosis and implementation of treatment with antimicrobials. More data on host susceptibility, stress factors, immune response and infectious dose levels are required. The impact of asymptomatic carriers, M. bovis survival in the environment and the role of wildlife in transmitting the disease also needs investigation. To facilitate development of vaccines, further analysis of more M. bovis genomes, its pathogenic mechanisms, including variable surface proteins, is required, along with reproducible disease models.
or is a more pervasive problem worldwide has not been reported in the currently available literature.
Buffaloes (Marouf, Mohamed, & EL-Jakee, 2011 ) and bison (Dyer, Hansen-Lardy, Krogh, Schaan, & Schamber, 2008) may become infected or act as carriers of M. bovis, with reports in sheep and goats (Kumar, Verma, Gangwar, & Rahal, 2012) , swine (Spergser, Macher, Kargl, Lysnyansky, & Rosengarten, 2013) , deer (Dyer, Krogh, & Schaan, 2004) and chickens (Ongor et al., 2008) . Diagnosis in sheep and goats is complicated by the biochemical and genetic similarity of M. bovis with Mycoplasma agalactiae, the latter causing contagious agalactia, a notifiable disease to the Office International Epizooties (OIE) World Organisation for Animal Health. M. bovis is not considered to be zoonotic, although a few cases have been reported in immunocompromised patients who have had close contact with infected cattle or their products such as infected milk or faeces (Pitcher & Nicholas, 2005) .
With M. bovis being increasingly recognized as a significant disease problem of cattle, it was included in the EU-funded DISCONTOOLS project in their disease database (DISCONTOOLS Disease Database, 2016 http://www.discontools.eu/Diseases/Detail/82; O'Brien, Scudamore, Charlier, & Delavergne, 2017) . Here, we review the current information available for M. bovis disease diagnosis and control and identify the gaps in current knowledge and the requirements to develop more effective tools for controlling this disease (Table 1) .
| THE CAUSATIVE ORGANISM
Mycoplasma species are distinguished by their lack of a cell wall, complex nutritional requirements and small genome. The twelve currently sequenced and complete M. bovis genomes range in size from 948,121 bp (Li et al., 2011) to 1,038,531 bp (GenBank: LT578453. 1), with a low guanine plus cytosine (GC) content of approximately 29.3%. These bacteria lack the tricarboxylic acid cycle (TCA), and their small genome size limits the range of their metabolic activities so they are largely dependent on external sources of amino acids, nucleic acid precursors and lipids. M. bovis does not ferment glucose or hydrolyse arginine , but instead uses organic acids such as lactate and pyruvate, as energy sources for growth. A recent metabolomics study has greatly increased both our knowledge base of key metabolites and our understanding of potential pathways important for M. bovis growth in vitro (Masukagami et al., 2017) . One product of metabolism is hydrogen peroxide, which may be a pathogenicity factor in mycoplasma infections Zhao et al., 2017) .
When M. bovis is grown in vitro in the laboratory, amino acids, nucleic acid precursors and other required nutrients need to be provided, so artificial growth media require cholesterol, serum and DNA.
The organisms grow slowly in air at 37°C, but prefer a capnophilic atmosphere, with high humidity. On solid agar, colonies exhibit distinctive "fried egg" morphology when viewed under a plate microscope, while film and spot formation can also be seen on the surface of solid media indicating the presence of lipolytic activity (Thorns & Boughton, 1978) . Due to the lack of a rigid cell wall, mycoplasmas are pleomorphic and therefore cannot be classified as either rods or cocci. The absence of a murein/peptidoglycan layer also increases mycoplasma's susceptibility to osmotic stress but renders them resistant to antimicrobials such as those of the beta-lactam, glycopeptide and cycloserine families, which all inhibit aspects of peptidoglycan synthesis (Rosenbusch, 1994) . While seemingly fragile, Justice-Allen et al. (2010) demonstrated the organisms' ability to survive in bedding sand for eight months.
Completely assembled genome sequences have been determined for twelve M. bovis isolates (including four derived from highly passaged isolates from strain HB0801 [Rasheed et al., 2017] ), with draft genomes available for 20 additional strains (NCBI database on 24 January 2018). To date, detailed comparative genomic analyses have only been reported on the first three complete M. bovis genomes to be sequenced (Li et al., 2011; Qi et al., 2012; Wise et al., 2011) and for the high-passage derivatives of HB0801 (Rasheed et al., 2017) .
Although the overall genomic framework and gene synteny are largely conserved, these are punctuated by incursions of integrative conjugative elements (ICE), variable copy numbers and integration sites of insertion sequences (IS) and a large chromosomal inversion in the PG45 type strain (generated by recombination between two IS units). Each genome has a different complement of restrictionmodification genes, predicting that these different strains will vary in genetic tractability.
Mycoplasma bovis strains typically possess a family of phase-and size-variable membrane surface lipoprotein antigens (Vsps); Behrens, Heller, Kirchhoff, Yogev, & Rosengarten, 1994) , which are among the major immunogenic antigens and have a role in adhesion to the host . These proteins spontaneously undergo noncoordinated phase variation between ON and OFF expression states.
The spontaneously high rate of Vsp phenotypic switching is due to DNA re-arrangements that occur at high frequency in the M. bovis chromosome (Lysnyansky, Sachse, Rosenbusch, Levisohn, & Yogev, 1999) . Comparative genomic analyses revealed distinctive repertoires of clustered vsp genes (the vsp locus is absent from strain Hubei-1) as well as different portfolios of additional surface lipoproteins. For example, the strain PG45 genome encodes 96 putative lipoprotein genes (including a 13-vsp gene cluster), whereas the HB0801 genome has seven lipoprotein genes that are not found in PG45, has a reduced vsp gene set of six members and lacks five genomically dispersed lipoprotein genes that are present in PG45. Also notable in the genomic comparisons, are examples where certain surface protein genes, although present in all three strains (and almost identical between the two Chinese isolates), were highly divergent between this pair and the corresponding ORFs in PG45. This was particularly evident in the~12-kb region encoding the putative MIP-MIB IgG protease gene locus (analogous to that described in Arfi et al., 2016) , where equivalently located ORFs share only 64%-78% amino acid sequence identity, in contrast to the >99% identity exhibited by flanking housekeeping genes. However, despite the high degree of variability between gene complement, both PG45 and HB0801 exhibited similar virulence when compared in a bovine infection T A B L E 1 Important knowledge gaps and questions relating to Mycoplasma bovis disease, prevention and control
Area
Knowledge gap | 93 study (Qi et al., 2012) . To date, only one study has been reported in which it was possible to correlate specific genes with pathogenicity.
By comparing 115-, 150-and 180-passage isolates (with decreasing pathogenicity) to the parental HB0801 isolate, ten metabolismrelated genes together with one variable surface protein-encoding gene were identified as germane to the observed attenuation (Rasheed et al., 2017) . However, no gene has been unambiguously demonstrated to influence the virulence profile of any M. bovis isolate in vivo.
The availability of multiple genome sequences has facilitated the development of additional molecular typing tools for population analysis. These include multiple locus variable number tandem repeat (VNTR) analysis (MLVA; Amram et al., 2013; Pinho, Thompson, Rosenbusch, & Carvalheira, 2012) and multilocus sequence typing methods (MLST) based on housekeeping genes (Register, Thole, Rosenbush, & Minion, 2015; Rosales et al., 2015) . These techniques complement those of pulsed-field gel electrophoresis (PFGE), random amplification of polymorphic DNA (RAPD), amplified fragment length polymorphism (AFLP) (McAuliffe, Kokotovic, Ayling, & Nicholas, 2004 ) and insertion sequence profiling (Miles, McAuliffe, Persson, Ayling, & Nicholas, 2005) and have the advantage of high portability.
These molecular profiling methods have been increasingly used to examine strain variability in different herds or during an outbreak.
Although there is a common theme that isolates can be assigned to one of only a few population clusters (or clonal complexes in the case of MLST studies), each cluster may contain more than a dozenrelated profiles (or sequence types for MLST data), depending upon the sample size, population under investigation and discriminatory power of the technique used. Recent studies exploiting these techniques have revealed the emergence of a dominant-type associated with mastitis in Israel , the appearance of a lineage associated with severe mastitis in Switzerland and Austria (Aebi et al., 2012 (Aebi et al., , 2015 B€ urki, Spergser, Bodmer, & Pilo, 2016; Spergser et al., 2013) and the predominance of a single cluster, which is linked to the selection of antimicrobial-resistant strains, in
France (Becker, Thibault, Arcangioli, & Tardy, 2015) . In another MLST study, no association was disclosed between sequence type and anatomical origin, although certain STs were only found in bison isolates (Register et al., 2015) . As with MVLA, MLST is able to distinguish different isolates within a herd (Rosales et al., 2015) , but a combination of the two approaches is predicted to give the greatest discriminatory resolution (Register et al., 2015) .
| Disease course
Mycoplasma bovis is a primary cause of calf pneumonia, although older cattle may also be affected as has been observed in northern
Italy (Radaelli et al., 2008) . Mortality can be 5% to 10% or even higher in severe cases, and morbidity can approach 35% . In pneumonia, M. bovis is nearly always associated with a range of other pathogens, where it may also have a synergistic role. At postmortem, lung lesions may be absent or confined to the apical lobes of the lung with reddish areas of multilobular consolidation (Radaelli et al., 2008) ; however, more extensive lesions, abscesses and microabscesses may be observed in severe cases . Bryson, Ball, & Forster, 1996) . Pneumonia may occur on its own or with other clinical signs including polyarthritis in feedlot cattle and otitis media in young calves (Maunsell & Donovan, 2009 ).
Mycoplasma bovis has been associated with subclinical, clinical or chronic mastitis and is a major problem for milk production and animal welfare in large dairy herds in the United States and a serious, though, sporadic disease in Europe and the Middle East (Nicholas, Fox, & Lysnyansky, 2016) . Acute cases can lead to severe damage to the udder, with one or all quarters being affected and with a serous or purulent exudate (Maunsell et al., 2011) . A high somatic cell count may occur along with atrophy of affected quarters, with potential spread between quarters. The clinical mastitic manifestation may include firm quarters, a sudden milk drop and failure of antimicrobial treatment. At the same time cows may not show any systemic signs in spite of the udder infection, although a mild mucoid discharge and arthritis may be present (Houlihan, Veenstra, Christian, Nicholas, & Ayling, 2007) . These workers also observed abortions in the mastitic cows with M. bovis being detected in an aborted foetus. The clinical disease can be self-limiting, disappearing within months of outbreaks, sometimes without deliberate intervention (Nicholas et al., 2016) .
Arthritis may be a sequel to the respiratory or mastitic form of the disease Wilson et al., 2007) . Lameness occurs with swelling of the joints, often accompanied by a slight elevation in temperature and, in some severe cases, reduced consumption of feed and debilitation .
Other clinical signs including keratoconjunctivitis (which may cause blindness), and otitis media (resulting in permanent head tilt), are reported from infected herds and often accompany respiratory infections . Isolations have been made from the brains of calves (one with neurological signs), while in another case, M. bovis was also associated with a large spheroidal fibrinous lesion in the heart Nicholas et al., 2008) . Such isolations indicate that for at least some strains, or in certain situations, M. bovis may be invasive with haematogenous spread to other tissues, including the brain (Rosales, Puleio, Loria, Catania, & Nicholas, 2017) .
Reproductive tract problems have been noted in both male and female animals following experimental infection with M. bovis or M. bovis-containing semen (Wrathall, Ayling, & Simmons, 2007) indicating that reduced reproductive performance may result from natural M. bovis infection. Eaglesome and Garcia (1990) found that high levels of M. bovis significantly reduced the ability of bovine sperm to penetrate and form pronuclei in hamster oocytes, leading to the suggestion that use of infected semen might adversely affect the fertilization process in cattle. Related to parturition, a recent publication raised awareness of the ability of M. bovis to cause infected seromas in multiple animals following Caesarean section. Despite intensive antimicrobial therapy with multiple antimicrobials, only one of six infected animals was successfully treated (Gille et al., 2016) .
| Disease transmission
Mycoplasma bovis is highly contagious, and transmission is generally thought to be by aerosol. However, calves are at high risk if fed milk from infected cows which may contain more than 10 6 colony-forming units (CFU) per ml. Experimental studies have demonstrated that the teat canal and genital tract are also routes of infection and that M. bovis can be passed from an infected dam to its foetus (Wrathall et al., 2007) . These routes of infection may lead to seminal vesiculitis and orchitis, as has been shown following experimental inoculation of the prepuce or urethra . In that study, a decrease in semen quality and shedding of M. bovis into the semen were also reported. The latter is important as chronic salpingitis has been reported following insemination with M. bovis-containing semen (Hirth, Nielsen, & Plastridge, 1966) . In addition, outbreaks of mastitis cases in two closed herds in Finland have been traced to M. bovis-contaminated semen used for artificial insemination (Haapala et al., 2018) . The survival of the organism in bedding (JusticeAllen et al., 2010) may represent an additional source of infection (Piccinini, Gosney, Snel, Luini, & Nicholas, 2015) .
It is suspected that stress of cattle through climatic changes, overcrowding or translocation may make the animals more susceptible to infection and subsequently trigger an outbreak (Bayoumi, Farver, Bushnell, & Oliveria, 1988; Boothby, Jasper, Zinkl, Thomas, & Dellinger, 1983; Knudtson, Reed, & Daniels, 1986) . Furthermore, there is an increased risk of mastitis linked to large herd size (Fox & Gay, 1993; Fox, Hancock, Mickelson, & Britten, 2003; Nicholas et al., 2016; . However, the greatest risk factor for an outbreak of mycoplasma mastitis appears to be associated with introduction of cattle from outside of the herd (Punyapornwithaya, Fox, Hancock, Gay, & Alldredge, 2010; Punyapornwithaya et al., 2011; Thomas, Willeberg, & Jasper, 1981) .
Coupled with the observations seen in the field, controlled experiments have seen the rate of M. bovis shedding increase when calves were exposed to varying climatic conditions (Woldehiwet, Mamache, & Rowan, 1990) . Such shifts in shedding patterns of M. bovis may be related to elevated peripheral levels of glucocorticoids as heat stress increased peripheral cortisol concentrations in calves (Stott, Wiersma, Menefee, & Radwanski, 1976) . Findings of studies carried out by Alabdullah and colleagues support the concept that elevated peripheral concentrations of glucocorticoids predispose the bovine to mycoplasma disease (Alabdullah, Fox, Gay, Barrington, & Mealey, 2015; Alabdullah, Schneider, & Fox, 2011) . Dexamethasone (0.4 mg/kg) was used as an experimental treatment in week old dairy calves, (Alabdullah et al., 2011) housed indoors under controlled climatic conditions, where such conditions were within the bovine thermoneutral zone (McDowell, 1972) . In this experiment, calves were exposed to experimental inoculation of M. bovis 
| Incubation period/shedding kinetic patterns
The incubation period for infection is difficult to define as it varies with the age of the animal and the clinical and pathological effects of infection. It is also possible that different field isolates exhibit variation in virulence, which would also likely impact this parameter.
The accuracy of diagnosis also affects the effectiveness of measuring the incubation period. In experimental infections, the incubation period for mastitis may just be a few days and 7 days for pneumonia. Punyapornwithaya et al. (2011) estimated the incubation period to be 13.6 days in one herd with an outbreak of mycoplasma mastitis, whereas in an earlier publication , the incubation period was reported to be typically between 2 and 6 days (depending on dose). The incubation period may also be affected by the infectious dose, the presence of co-infectants, herd management and stress state of the animals, particularly following translocation.
Shedding of M. bovis is intermittent so diagnosis by detection of the organism in individual animals may be variable (Biddle, Fox, & Hancock, 2003) . Therefore, herd diagnosis particularly by cheaper serological methods may be more reliable for persistent infections. The ability to detect M. bovis is also dependent on sampling technique, how quickly the samples reach the diagnostic laboratory and how the samples have been stored (Biddle, Fox, Hancock, Gaskins, & Evans, 2004) . It is known that infected cattle can shed the organism for months (Biddle et al., 2003) , possibly years (Bayoumi et al., 1988) , and are therefore a source of reinfection and subsequent outbreaks of clinical disease.
| Mechanisms of pathogenicity
Studies of M. bovis pathogenesis have been hindered by the lack of a robust animal model, the costs and logistics associated with large animal studies and the relative lack of genetic tools, although the latter is being mitigated by the recent development of useful vectors and transformation systems (Bonnefois et al., 2016; ChopraDewasthaly, Zimmermann, Rosengarten, & Citti, 2005; Li et al., 2015; Sharma, Citti et al., 2015) . Nevertheless, progress has been made in certain critical areas of pathogenesis, most notably in the identification of adhesins and in function assignment of additional surface proteins (Adamu, Wawegama, Browning, & Markham, 2013) .
Although a role in adherence for the Vsp family of surface lipoproteins was established two decades ago (Sachse et al., , 2000 , recent studies have identified additional candidate adhesins based on properties of recombinant forms of the proteins or antibody blocking studies. These include the Vpmax adhesin (Zou et al., 2013) , which shares the property of internal peptide repeats with certain Vsp proteins, and three metabolic enzymes that exhibit adherence properties as an apparent moonlighting function. Thus, M. bovis enolase, a key enzyme of the glycolytic pathway, has been shown to bind embryonic bovine lung (EBL) cells through interaction with plasminogen, which expands the number of pathogens for which enolase contributes to cytadherence (Song et al., 2012) . Binding to EBL cells and plasminogen was also demonstrated for the M. bovis TrmFO protein (predicted to function as a tRNA methyltransferase; . Intriguingly, TrmFO exhibits reduced expression in an attenuated, high-passage M. bovis isolate. Recently, NADH oxidase (Nox) was shown to have both hydrogen peroxide generating activity (a possible virulence attribute) and an adherence function (Zhao et al., 2017) . Based on a high degree of sequence similarity (44% amino acid sequence identity; 63% similarity) and conserved genomic context, M. bovis MBOVPG45_0378 is an unambiguous ortholog of the recently described P19 adhesin of the bovine pathogen M. mycoides subsp mycoides (Small Colony); (Zhou et al., 2016) . Although a recombinant form of the latter has been shown to bind EBL cells and anti-P19 sera can block M. mycoides binding to EBL cells, possible adhesin-related functions for MBOVPG45_0378 have not yet been reported.
Virulence mechanisms have been reported that relate to persistence and possible avoidance of the host immune response which may result in chronic infections. The genes for multiple surface components undergo high-frequency, reversible variation in expression, which is predicted to limit exposure to immune surveillance. The Vsp family of lipoproteins is one such system whereby an expanding population of cells can generate different lineages expressing one predominant Vsp protein (reviewed in B€ urki, Frey, & Pilo, 2015) . This system is orchestrated by a single recombinase that mediates DNA inversions such that one vsp gene is oriented downstream of the single promoter in the vsp multigene locus (Lysnyansky, Ron, & Yogev, 2001 ). In addition, these surface lipoproteins are predominantly comprised of tandemly repeated blocks of amino acid sequences, the gene sequences for which undergo high frequency expansion and contraction during DNA replication, presumably by a slipped-strand mispairing mechanism. Such changes in repeat length may impact adherence (Sachse et al., 2000) , although roles in biofilm formation (McAuliffe, Ellis, Miles, Ayling, & Nicholas, 2006) , sensitivity to phagocytosis and complement-mediated killing (Shaw, Simmons, & Dybvig, 2012) and molecular shielding of antigens (Citti, Kim, & Wise, 1997) are also possible based on precedents set by analogous repeat-containing lipoproteins in other Mycoplasma species.
Comparative genomic analysis has also identified other putative Although antigenic variation may reduce immune recognition of membrane proteins encoded in contingency loci, constitutive expression is envisaged to be necessary for many important surface proteins involved in host adaptation and nutrient acquisition. Host antibodies that recognize such surface components would be predicted to result in compromised function and/or pathogen clearance.
In this context, the recently described mycoplasmal MIP-MIB system may limit engagement by immunoglobulin molecules (Arfi et al., 2016) . Although not formally demonstrated for the system identified in M. bovis, that in M. mycoides subsp. capri has been shown to express two surface proteins, one that selectively binds IgG (designated MIB) and a partner that functions as a protease (MIP) that cleaves IgG heavy chains. This system is widely distributed among
Mycoplasma species and multiple copies of the mip and mib genes are clustered in the M. bovis genomes sequenced to date.
An increasingly recognized strategy that is predicted to afford protection from immune surveillance is the ability of M. bovis to invade and replicate in diverse bovine peripheral blood mononuclear cell types and erythrocytes (van der Merwe, Prysliak, & Perez-Casal, 2010 ). The invasion of circulating immune cells and erythrocytes should not only play an important role in pathogenicity, potentially protecting the pathogen from the host immune response and administered antimicrobials, but could also promote persistence and further dissemination of the pathogen between organ systems. M. bovis antigens have also been visualized in hepatocytes and epithelial cells (Maeda et al., 2003) , and invasion followed by intracellular replication has been demonstrated in primary embryonic calf turbinate cells (B€ urki, Gaschen et al., 2015) , as well as in bovine embryonic tracheal epithelial cells (Suleman et al., 2016) . Although much awaits to be discerned about the pathways for entry and survival in these privileged niches, recent advances in molecular tools and imaging techniques should expedite our understanding of these processes.
One aspect of pathogenesis that warrants further comment is the ability of many Mycoplasma species to form biofilms, with M. bo- as assessed by Western analysis (Robino et al., 2005) , and the p48 gene was detected in all seventeen M. bovis field isolates by Southern analysis (Lysnyansky et al., 2008) . The apparent ubiquitous nature of P48 and its cognate gene is in contrast to the paralog, p68, which exhibited strain-variable distribution with only eleven of the seventeen strains displaying p68 hybridization signals (Lysnyansky et al., 2008) . It is important to note that although multiplex detection may help in the diagnosis of mixed mollicute infections, it may introduce additional complexity into the determination of disease aetiology; multiple mycoplasma species may be found, for example, in the upper respiratory or genital tracts that are apparent commensals with questionable significance in disease (Brown et al., 2015) . antibody detection ELISA is considered to be specific (Liberal & Boughton, 1994) , which is also supported by the phylogenetic separation of M. bovis from most other bovine mycoplasma species (Brown et al., 2015) . Detection of anti-M. bovis antibodies is usually used for herd screening, as, on an individual animal level, titres may sometimes correlate poorly with infection or disease (Maunsell et al., 2011) . Furthermore, immunological tests are only effective once an animal seroconverts and thus will only demonstrate previous exposure to the pathogen. Nasal carriage alone may lead to seroconversion without clinical disease presentation (Bennett & Jasper, 1977; Pf€ utzner & Schimmel, 1985) , but the presence of such carrier animals in a herd is important to identify as a potential reservoir for subsequent disease in other individuals (Pf€ utzner & Schimmel, 1985) . The presence of M. bovis antigen in formalin-fixed paraffinembedded tissue sections may also be used for diagnosis and can be detected by immunohistochemical analysis (Adegboye et al., 1995) .
| Detection
Other tests being developed for either direct or indirect M. bovis detection include latex agglutination tests, lateral flow devices and resonance devices. It should be noted that for many of the available tests, intermittent shedding of organisms and potential inhibitors present in milk may reduce the effectiveness of testing on any given platform. Previous studies have noted that the limits of detection for several bacterial species, including M. bovis, are at least 10-fold greater for milk than for other matrices (Hotzel et al., 1996; Sachse et al., 1993 ). There is also interest in developing attenuated live vaccine strains and subunit vaccines for M. bovis. Zhang et al. (2014) reported that a multipassaged attenuated M. bovis strain provided protection against virulent infection in calves. However, other workers attempting to develop vaccines have been less successful. Bryson, Ball, Foster, and Brice (2002) enhanced the severity of pneumonia in calves using Triton X-114 membrane protein extracts and mixtures of affinity-purified antigens. Other experimental work in Canada using membrane fractions (Mulongo, Prysliak, & Perez-Casal, 2013 ) and recombinant proteins including glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has also failed to protect cattle against challenge with M. bovis (Prysliak, van der Merwe, & Perez-Casal, 2013; van der Merwe, Prysliak, Gerdts, & Perez-Casal, 2011) . Immunoproteomic analysis (identification of immunoreactive proteins with sera from experimentally infected or naturally infected cattle) has been used to identify additional M. bovis surface proteins that have proven suitable for ELISA development, but that may also be exploitable as possible subunit vaccine candidates. These include the MbovP579 lipoprotein of unknown function (Khan et al., 2016) and MilA, a putative lipase related to the GDSL family (Wawegama, Browning, Kanci, Marenda, & Markham, 2014) . A similar immunoproteomic study led to the identification of ten M. bovis antigens of which five (PdhA, EF-Tu, O256, P48 and Lpp) could induce robust IgG1 and IgG2 responses, when used as recombinant proteins formulated with the commercial adjuvant Emulsigen â together with poly I:C and IDR peptide 1002 (Prysliak & Perez-Casal, 2016 ). It will be of interest to determine whether any of these antigens, either singularly or in combination, will afford protection as a (multi-)subunit immunotherapeutic.
| Control
Severe cases of infection require culling on animal welfare grounds, which also reduces the load of infection on heavily infected premises. However, in some cases the clinical disease is self-limiting, disappearing within months without deliberate intervention, so culling may not always be required (Nicholas et al., 2016) .
| GAP ANALYSIS

| Mycoplasma bovis
The true incidence of M. bovis is not very well known with most of the available information emanating from passive surveillance data.
Both serological and abattoir surveys should provide a more accurate assessment of its true prevalence. The real economic cost of the disease has not been determined; a detailed analysis of all cost factors such as mortality, veterinary costs, treatment, milk loss, added housing/feed costs through lack of weight gain would yield a more com- . In addition, no significant difference in disease severity was observed when strains PG45 and HB0801
were compared in a small-scale study (three animals per group), despite a number of genomic differences between the two isolates (Qi et al., 2012) . In contrast, an experimental infection study has demonstrated that certain field isolates do differ in their ability to cause gross lung pathology within a 4-week investigational period (R. A. J. Nicholas and R. D. Ayling, unpublished) . This was despite the fact that all isolates used in these studies were recovered from chronic M. bovis infections. These disparate findings highlight the need for further comparisons of field isolates. Sharma, Citti et al., 2015) and may be used in conjunction with in vitro and in vivo screening models for identification of M. bovis virulence factors and understanding its pathogenesis. These approaches may also allow for improved molecular typing schemes such as a whole-genome based "typing scheme" that may enable "types" to be correlated with pathogenicity/clinical signs, which should be the ultimate goal. The different molecular types identified by the various schemes (Amram et al., 2013; B€ urki et al., 2016; McAuliffe et al., 2004; Miles et al., 2005; Register et al., 2015; Rosales et al., 2015) have not disclosed signatures for lineages that are either more pathogenic or related to one or more of the different clinical conditions of mastitis, arthritis or pneumonia. Further analysis relating molecular types to disease, clinical signs, epidemiology, population structure and evolution would be beneficial.
| Disease course
A major unknown is why and how M. bovis can cause so many different clinical signs and why in some cases it manifests as pneumonia, arthritis, mastitis, otitis media, keratoconjunctivitis or genital infections, infertility or abortion. It is not known how the organism circulates in the host and it has only relatively recently been shown to be able to persist intracellularly in vitro (B€ urki, Gaschen et al., 2015; van der Merwe et al., 2010) . It is thought that the animal's immune response contributes to lesion development, at least at the chronic stage, but this is not fully understood (Kauf, Rosenbusch, Paape, & Bannermann, 2007) . Field cases of pneumonia are probably more long-lasting and more influenced by the co-infectants present;
however, the underlying interactions are not well understood. Both potential strain variability and herd management differences may impact the length of the incubation period making this a relatively unknown factor in the control of the disease. The role of the asymptomatic carrier in a herd outbreak is again largely unknown. Factors that affect virulence in disease such as the role of variable surface proteins or M. bovis-produced metabolites still need to be ascertained in molecular detail. Possible differences in the route of infection, infectious dose, host susceptibility, age and breed also require investigation. Instances where just a few sero-positive animals are present within large sero-negative herds may be due to lack of test sensitivity or require additional studies on the epidemiology of transmission. Calf pneumonia is undoubtedly higher during colder seasons with M. bovis pneumonia appearing to account for approximately 20%-30% of infections . Temperature fluctuations are more likely to be a key factor in disease and not just exposure to the cold, again highlighting the need to understand the effect of stress on the hosts' disease susceptibility, which includes weather, translocation and housing. Poor housing conditions are probably an important contribution to pneumonia in winter conditions. In seasons of reduced pneumonia, M. bovis may account for a higher percentage of pneumonic cases.
The few infections that have been reported in humans have caused respiratory disease, bronchopneumonia and were probably related to immunosuppression; however, there is a possibility of under-reporting as its specific diagnosis would not generally be considered by a physician. There is a need to raise potential awareness as well as a need to better understand the risk factors and transmission pattern for M. bovis infection in humans. as "key players" in the immune function networks (Behura et al., 2017) . In addition, recent analysis of microRNAs circulating in sera from beef cattle that had been naturally or experimentally infected with M. bovis has identified four microRNAs (bta-let-7b, bta-miR-24-3p, bta-miR-92a and 423-5p) that are associated with a humoral antibody response (Casas et al., 2016) . Each of these molecules had (Singh, Reilly, Calcutt, & Tanner, 2011) . Although these may function in nucleotide acquisition, the preferred substrates for these enzymes are currently unknown and a possible role in virulence is possible based on the finding that generation of adenosine from AMP is known to promote immune escape for Staphylococcus aureus and Bacillus anthracis (Thammavongsa, Kern, Missiakas, & Schneewind, 2009 
| Detection
Intermittent shedding of organisms and potential inhibitors present in milk may reduce the sensitivity of current antigen and molecular detection tests, most likely through high lipid content or binding of mycoplasma to milk proteins and subsequent loss during DNA extraction (Hotzel et al., 1996; Sachse et al., 1993; Usman, Yu, Liu, Fan, & Wang, 2014 Some isothermal amplification tests such as LAMP have been reported (Ashraf et al., 2017; Bai et al., 2011; Higa et al., 2016) , but they are not in routine use. Although this is possibly due to recent development, specificity and contamination are potential challenges also (Lau & Botella, 2017; Wong et al., 2018) . Multiplexed testing for different organisms associated with BRD would facilitate improved and more rapid diagnosis. Moreover, there has been little progress in serology of mycoplasmal infections in the last two decades. Novel approaches using epitope-derived synthetic peptides to capture cognate antibodies in ELISA or microarray format could generate powerful tools for rapid and specific diagnosis at both herd and individual animal levels (Rahman et al., 2015) . Altogether, there is considerable potential for the development of more specific and sensitive tests. The availability of specific and rapid pen-side tests combined with improved and expedient antimicrobial sensitivity testing would greatly help the implementation of targeted control methods.
| Control
Much knowledge on the causative risk factors is required to control herd-level outbreaks. Therefore, suitable intervention methods may be able to be designed and implemented without generating substantial economic losses and high treatment costs. determined. This is difficult and expensive to conduct using animal models; however, the use of molecular methods to determine resistance and relating that to MIC values would be a more realistic approach. These tests should take into account the possible impact of biofilm formation. The development of new or alternative antimicrobials is required by screening novel chemicals, plant extracts and antimicrobial peptides from diverse sources. However, proper regard will need to be given to meat and milk withdrawal times for any newly developed pharmaceuticals. Early recognition and treatment of disease are essential; however, some reports indicate that prolonged therapy or metaphylaxic dosing of whole groups is required, but this contradicts recommendations for reducing antimicrobial use.
| Vaccines
Improved vaccines are clearly required urgently, which in the ideal world would be (i) safe, (ii) effective against all disease manifestations, (iii) usable at all stages of animal production, (iv) active against all M. bovis isolates (including strains that may be genetically distinct or that exhibit different surface antigen repertoires), (v) stable, (vi) preferably single shot and included within multivalent BRD vaccines, (vii) provide long-term effective protective immunity and (viii) be usable in all countries. Live vaccines should not be ruled out as the literature shows that, to date, the most successful mycoplasma vaccines have been live attenuated strains such as the T1/44 for contagious bovine pleuropneumonia and those for avian mycoplasmosis (Nicholas, Ayling, & McAuliffe, 2009 ). serially passaged a strain of M. bovis and showed the loss of a potential pathogenic factor linked to hydrogen peroxide production. These lineages should be tested in animals to determine whether they are attenuated, as has been established recently for a series of highly passaged M. bovis strains (derived from the sequenced strain HB0801), which also exhibited reduced hydrogen peroxide elaboration (Rasheed et al., 2017) . Sequence analysis of the latter strains Ideally, the vaccine should be part of a multicomponent vaccine against the diverse aetiological agents associated with BRD. Depending on when a candidate vaccine could be identified, its development, clinical trials and licensing means it could be 5-10 years before it become available commercially.
| CONCLUSION
There is a worldwide problem of disease caused by M. bovis, which has a significant economic impact on cattle rearing. It is a major constraint on intensive production affecting intensive beef production, particularly in feedlots and milk production in high yielding herds. The following factors summarize the problems: (i) no effective vaccines are available, (ii) latent infections are not always easily diagnosed, (iii) it is difficult to eliminate from a herd, (iv) it is difficult to assess the cause of the bovine respiratory disease complex when a number of other pathogens are also involved, and finally, (v) M. bovis has developed antimicrobial resistance to many of the antimicrobials currently in use. Currently, there has been limited investment, and little progress has been made to even begin addressing the disease and animal health welfare issues caused by M. bovis.
